BAYER AKTIENGESELLSCHAFT «12345...» Página 5 de 137 desde 01/07/1988 hasta 22/05/2024 13/05/2019 14:14 BAYER AKTIENGESELLSCHAFT R&D: new licenses, patents and registered trademarks Not intended for U.S. and UK: Bayer to present new data at ASCO 2019 highlighting commitment to evolve cancer treatment paradigm Número de registro: 278168 29/04/2019 14:16 BAYER AKTIENGESELLSCHAFT R&D: new licenses, patents and registered trademarks Not intended for U.S. and UK: U.S. - FDA accepts New Drug Application and grants Priority Review for darolutamide Número de registro: 277551 29/04/2019 08:01 BAYER AKTIENGESELLSCHAFT Announcements and resolutions of general shareholders meetings Bayer’s Supervisory Board unanimously stands behind Board of Management Número de registro: 277508 26/04/2019 10:38 BAYER AKTIENGESELLSCHAFT Information on P&L "We made great progress – both operationally and strategically” Número de registro: 277464 25/04/2019 09:26 BAYER AKTIENGESELLSCHAFT Information on P&L Bayer AG: Public Information refered to Q1-2019 Número de registro: 277392 25/04/2019 08:03 BAYER AKTIENGESELLSCHAFT Information on P&L Bayer: strong operational start to the year Número de registro: 277377 25/04/2019 07:59 BAYER AKTIENGESELLSCHAFT Information on P&L Bayer: Q1 2019 Analyst and Investor Briefing Número de registro: 277376 23/04/2019 11:08 BAYER AKTIENGESELLSCHAFT Announcements of public presentations and meetings Bayer: Save-the-Date for Crop Science Summer Technology Showcase on August 1 - 2, 2019 Número de registro: 277260 11/04/2019 11:04 BAYER AKTIENGESELLSCHAFT Announcements of public presentations and meetings Bayer: Q1 2019 Publication Schedule Número de registro: 277004 28/03/2019 08:34 BAYER AKTIENGESELLSCHAFT Legal disputes Bayer statement on jury’s decision in phase two of California glyphosate trial. Número de registro: 276497 Página 5 de 137 «12345...»